NCT03570645View on ClinicalTrials.gov

Comparison of the Duration of Ropivacaine Combined With Dexmedetomidine or Dexamethasone on Paravertebral Block

PHASE4CompletedINTERVENTIONAL

Enrollment

154

Participants

Timeline

Start Date

July 12, 2019

Primary Completion Date

November 11, 2019

Study Completion Date

November 18, 2019

Conditions

Lung Cancer

Interventions

DRUG

Dexmedetomidine Group

combination of ropivacaine and dexmedetomidine 100 ug every time

DRUG

dexamethasone group

combination of ropivacaine and dexamethasone 10mg every time

DRUG

control group

block with only ropivacaine

Trial Locations (1)

110001

Department of Anesthesiology, the First Hospital of China Medical University, Shenyang

All Listed Sponsors

lead

China Medical University, China

OTHER

NCT03570645 - Comparison of the Duration of Ropivacaine Combined With Dexmedetomidine or Dexamethasone on Paravertebral Block | Biotech Hunter | Biotech Hunter